Consolidated Balance Sheets - USD ($) $ in Millions	Dec. 31, 2025	Dec. 31, 2024
Investments:
Available-for-sale, Debt Securities, Excluding Securities Valued at Fair Value Option	$ 20,862	$ 17,848
Fixed maturities, at fair value using the fair value option	1,131	1,197
Equity Securities, FV-NI, Current	72	66
Short-term investments	6	20
Financing Receivable, after Allowance for Credit Loss, Current	4,575	3,613
Policy loans	157	163
Limited partnerships/corporations	1,365	1,227
Derivatives	154	239
Other Investments	61	94
Total investments	29,228	25,556
Cash and cash equivalents	352	516
Short-term investments under securities loan agreements, including collateral delivered	791	839
Accrued investment income	300	276
Premiums and Other Receivables, Net	2,421	2,560
Deferred Policy Acquisition Costs and Present Value of Future Insurance Profits, Net	1,257	907
Deferred Income Tax Assets, Net	513	662
Other assets (net of allowance for credit loss of $0 as of 2025 and 2024)	2,795	1,396
Separate Account Asset	109,772	98,579
Total assets	147,429	131,291
Liabilities and Shareholder's Equity
Future policy benefits and contract owner account balances	33,244	29,268
Payables under securities loan and repurchase agreements, including collateral held	826	897
Related Party Deposit Liabilities	124	100
Derivatives	232	268
Other liabilities	806	639
Separate Account, Liability	109,772	98,579
Total liabilities	145,004	129,751
Commitments and Contingencies (Note 15)
Shareholder's equity:
Common Stock, Value, Issued	3	3
Additional paid-in capital	2,929	2,754
Accumulated other comprehensive income (loss)	(1,134)	(1,644)
Retained earnings	627	427
Total shareholder's equity	2,425	1,540
Total liabilities and shareholder's equity	147,429	131,291
Collateral Pledged
Investments:
Debt Securities, Available-for-Sale, Restricted	$ 845	$ 1,089